Reconstitution of tumor-bearing BCDM with WT B cells, but not PD-L1−/− or IL-10−/− B cells, could restore tumor growth in oxaliplatin-treated mice, implicating both PD-L1 and IL-10 in mediating the Breg suppressive effects. The gene discussed is CD274; the disease is neoplasm.